OA11632A - Treatment of diabetes with thiazolidinedione and sulphonylurea. - Google Patents

Treatment of diabetes with thiazolidinedione and sulphonylurea. Download PDF

Info

Publication number
OA11632A
OA11632A OA1200000014A OA1200000014A OA11632A OA 11632 A OA11632 A OA 11632A OA 1200000014 A OA1200000014 A OA 1200000014A OA 1200000014 A OA1200000014 A OA 1200000014A OA 11632 A OA11632 A OA 11632A
Authority
OA
OAPI
Prior art keywords
insulin
compound
composition according
suedes
dione
Prior art date
Application number
OA1200000014A
Other languages
English (en)
French (fr)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA11632(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA11632A publication Critical patent/OA11632A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA1200000014A 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione and sulphonylurea. OA11632A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715306A GB9715306D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
OA11632A true OA11632A (en) 2004-11-22

Family

ID=10816177

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200000014A OA11632A (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione and sulphonylurea.

Country Status (41)

Country Link
EP (1) EP0998291B2 (ko)
JP (2) JP2001510158A (ko)
KR (1) KR100680667B1 (ko)
CN (1) CN1264302A (ko)
AP (1) AP1318A (ko)
AR (2) AR016768A1 (ko)
AT (1) ATE366577T1 (ko)
AU (1) AU743269B2 (ko)
BG (1) BG64892B1 (ko)
BR (1) BR9810904A (ko)
CA (1) CA2297115C (ko)
CO (1) CO4940422A1 (ko)
CY (1) CY1107745T1 (ko)
CZ (1) CZ302668B6 (ko)
DE (1) DE69838066T3 (ko)
DK (1) DK0998291T4 (ko)
DZ (1) DZ2564A1 (ko)
EA (1) EA003303B1 (ko)
ES (1) ES2290989T5 (ko)
GB (1) GB9715306D0 (ko)
HK (1) HK1029272A1 (ko)
HU (1) HU229119B1 (ko)
ID (1) ID24198A (ko)
IL (1) IL134045A0 (ko)
IN (1) IN189035B (ko)
MA (1) MA26522A1 (ko)
MY (1) MY138246A (ko)
NO (1) NO326356B1 (ko)
NZ (3) NZ501256A (ko)
OA (1) OA11632A (ko)
PE (1) PE99799A1 (ko)
PL (2) PL338127A1 (ko)
PT (1) PT998291E (ko)
SI (1) SI0998291T2 (ko)
SK (2) SK288053B6 (ko)
TR (1) TR200000135T2 (ko)
TW (1) TW586926B (ko)
UA (1) UA70302C2 (ko)
UY (1) UY25103A1 (ko)
WO (1) WO1999003476A1 (ko)
ZA (1) ZA986365B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1897547A1 (en) * 1999-07-13 2008-03-12 Medicure Inc. Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
EP1832291A3 (en) * 1999-07-13 2009-11-04 Medicure Inc. use of pyridoxal phosphate for the treatment of diabetes and related complications
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
CA2725833A1 (en) 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
SI1677792T1 (sl) * 2003-10-31 2016-02-29 Takeda Pharmaceutical Company Limited Trden pripravek, ki obsega pioglitazon, glimepirid in polioksietilen sorbitan maščobnokislinski ester
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法
PE20110019A1 (es) 2005-12-22 2011-01-27 Takeda Pharmaceutical Composicion farmaceutica que contiene un sensibilizante de insulina y un secretagogo de insulina

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
ATE139130T1 (de) * 1991-08-16 1996-06-15 Sandoz Ag Inhalator zur verabreichung von pulverförmigen substanzen
US5900435A (en) * 1991-08-26 1999-05-04 Pharmacia & Upjohn Company Composition, food product and uses of 3-guanidinopropionic acid
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
AR016768A1 (es) 2001-08-01
DE69838066T2 (de) 2008-03-20
EA003303B1 (ru) 2003-04-24
ID24198A (id) 2000-07-13
CN1264302A (zh) 2000-08-23
DE69838066T3 (de) 2012-03-29
BG64892B1 (bg) 2006-08-31
TW586926B (en) 2004-05-11
PE99799A1 (es) 1999-12-22
PL338127A1 (en) 2000-09-25
BR9810904A (pt) 2000-09-26
DE69838066D1 (de) 2007-08-23
NO20000229L (no) 2000-01-17
HUP0003634A2 (hu) 2001-07-30
EA200000141A1 (ru) 2000-08-28
NO20000229D0 (no) 2000-01-17
KR100680667B1 (ko) 2007-02-09
UA70302C2 (uk) 2004-10-15
EP0998291A1 (en) 2000-05-10
DZ2564A1 (fr) 2003-02-15
AU743269B2 (en) 2002-01-24
SI0998291T2 (sl) 2011-10-28
CZ2000173A3 (en) 2001-05-16
IN189035B (ko) 2002-12-07
PT998291E (pt) 2007-10-11
WO1999003476A1 (en) 1999-01-28
EP0998291B1 (en) 2007-07-11
SK602000A3 (en) 2000-07-11
SK288053B6 (sk) 2013-03-01
TR200000135T2 (tr) 2000-05-22
CA2297115C (en) 2010-02-23
CY1107745T1 (el) 2013-04-18
HK1029272A1 (en) 2001-03-30
AP2000001734A0 (en) 2000-03-31
AU8448798A (en) 1999-02-10
ZA986365B (en) 2000-01-17
IL134045A0 (en) 2001-04-30
DK0998291T3 (da) 2007-11-05
SI0998291T1 (sl) 2007-12-31
CZ302668B6 (cs) 2011-08-24
JP2001510158A (ja) 2001-07-31
AR019331A2 (es) 2002-02-13
KR20010021948A (ko) 2001-03-15
CO4940422A1 (es) 2000-07-24
NZ515555A (en) 2002-09-27
CA2297115A1 (en) 1999-01-28
ATE366577T1 (de) 2007-08-15
GB9715306D0 (en) 1997-09-24
ES2290989T5 (es) 2011-11-11
JP2005247865A (ja) 2005-09-15
AP1318A (en) 2004-10-22
HUP0003634A3 (en) 2003-04-28
EP0998291B2 (en) 2011-07-06
UY25103A1 (es) 2000-12-29
SK287823B6 (sk) 2011-11-04
HU229119B1 (en) 2013-08-28
NO326356B1 (no) 2008-11-17
PL199125B1 (pl) 2008-08-29
NZ501256A (en) 2002-09-27
NZ520652A (en) 2004-06-25
ES2290989T3 (es) 2008-02-16
BG104139A (en) 2000-11-30
MY138246A (en) 2009-05-29
MA26522A1 (fr) 2004-12-20
DK0998291T4 (da) 2011-09-26

Similar Documents

Publication Publication Date Title
US20080058388A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
AP1352A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide.
JP2005247865A (ja) チアゾリジンジオンおよびスルホニル尿素を用いる糖尿病の治療
AU8449098A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
WO1998057649A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
SK179499A3 (en) The use of insulin sensitiser and alpha-glucosidase inhibitive antihyperglycaemic agent
US20040122060A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
US20040176420A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
US20020082284A1 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
AU783539B2 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
US20030092750A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
WO1999018944A1 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
EP1023056A1 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
AU2928002A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide